Lantern Pharma issues unregistered warrants in private placement for 2,135,923 shares
PUBT · 2d ago
Share
Listen to the news
- Lantern Pharma priced a $4.4 million registered direct offering of 2,135,923 common shares, or pre-funded warrants, at $2.06 per share.
- Concurrent private placement to issue unregistered warrants for up to 2,135,923 shares, exercisable at $2.27 per share.
- Warrants become exercisable six months after issuance, expire five years after first exercise.
- Full cash exercise would add about $4.85 million in gross proceeds, taking total potential proceeds to about $9.25 million.
- Closing expected on or about May 14, 2026; proceeds earmarked for working capital, general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantern Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605130800BIZWIRE_USPR_____20260513_BW454439) on May 13, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved